Pfizer cuts price of Prevnar for Third World
March 24, 2010 12:00 am
• Last Updated: March 24, 2010 2:05 am
Major drug companies Pfizer Inc. and GlaxoSmithKline have agreed to supply pneumonia-prevention vaccines to some of the world's poorest countries at a fraction of the price paid in the West.
The 10-year agreement with the GAVI Alliance announced Tuesday will be funded with an initial $1.5 billion contribution from five countries and the Bill & Melinda Gates Foundation.
Drug companies will provide medicines at $3.50 a dose in a program expected to save nearly a million lives in the first five years.
Pfizer, with R&D campuses in Groton and New London, will provide doses of its pneumococcal vaccine Prevnar.
- Lee Howard
Comment threads are monitored for 48 hours after publication and then closed.